Myeloproliferative neoplasms trials in China
30 trials · From ClinicalTrials.gov, checked 12 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking people68Ga-FAPI PET/CT Imaging for Diagnosis, Grading, and Efficacy Evaluation of Myelofibrosis.
- Where
- Xiamen
- Age
- 18 years and over
- People
- 90
- Run by
- The First Affiliated Hospital of Xiamen University
See details and how to joinNCT06151119 - No phaseTaking peopleEfficacy and Safety of Peginterferon in ET and PV.
- Where
- Wuhan
- Age
- 18 years and over
- People
- 40
- Run by
- Zhenya Hong
See details and how to joinNCT06734637 - Phase 2Taking peoplePegylated Interferon α-2b in Combination With Ruxolitinib for Treating Hydroxyurea-resistant/Intolerant PV
- Where
- Tianjin
- Age
- 18 years and over
- People
- 94
- Run by
- Institute of Hematology & Blood Diseases Hospital, China
See details and how to joinNCT05870475 - Phase 2Taking peopleClinical Study of Azacitidine Combined With Ruxolitinib in the Treatment of Higher-risk MDS/MPN
- Where
- Nanjing
- Age
- 18 years to 80 years
- People
- 50
- Run by
- The First Affiliated Hospital with Nanjing Medical University
See details and how to joinNCT05817955 - Phase 2Taking peopleOlverembatinib for FGFR1-rearranged Neoplasms
- Where
- Suzhou
- People
- 20
- Run by
- The First Affiliated Hospital of Soochow University
See details and how to joinNCT05521204